This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Sartorius Stedim Biotech Gmbh, Sartorius Stedim Cellca Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Christoph Zehe: Innovator in Biopharmaceuticals
Introduction: Christoph Zehe is an inventor based in Ulm, Germany, who is currently associated with Sartorius Stedim Data Analytics AB. Although he does not hold any granted patents, his contributions to the field of biopharmaceuticals are noteworthy. He works alongside colleagues Rickard Sjögren and Christoffer Edlund, focusing on innovative solutions in data analytics.
Latest Patent Applications: Christoph Zehe has filed several patent applications that reflect his expertise in genomic editing and quality control in biopharmaceutical manufacturing. One of his latest applications is titled "Genome Editing with CRISPR/Cas Nucleases Comprising Collateral Activity." This invention describes a method for editing the genomic sequence of cells using an endonuclease capable of collateral cleavage of RNA and/or DNA. Another significant application is "Computer Vision Based Monoclonal Quality Control," which outlines a computer-implemented method for monitoring the quality of cell growth in the development of cell lines for biopharmaceuticals. This method involves acquiring and processing images of cell cultures to evaluate compliance with predetermined conditions characteristic of monoclonal growth.
Conclusion: Christoph Zehe's work in the field of biopharmaceuticals, particularly in genomic editing and quality control, showcases his innovative spirit and dedication to advancing technology in healthcare. His latest patent applications highlight the potential impact of his research on the industry.